Among these clinical variables, only kallistatin concentration was emphasized in this study because a previous our proteomics study showed that low serum kallistatin levels in cardiac arrest patients were associated with poor neurological outcomes in cardiac arrest survivors. Here, SERPINA4 is linked to cardiac arrest.